The 2026 Activated Egg Symposium, titled "Unique Human Egg Activation Pathways," will convene internationally recognized scientists and clinicians in Boston for a one-day meeting focused on how human eggs activate and initiate early embryonic development. Hosted by the Bedford Research Foundation, the symposium continues a series that began in 2002 and is designed to foster scientific exchange, spark new collaborations, and bring together experts from academia, fertility clinics, and biotechnology.
The event matters because fundamental questions about human egg activation remain unanswered, and resolving them could open new possibilities in reproductive and regenerative medicine. As Ann A. Kiessling, Director of the Bedford Research Foundation, noted, "We still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine." The symposium's focus on molecular and cellular mechanisms that shape egg activation, fertilization, and developmental competence places it at the intersection of fertility science and stem cell research.
The program will feature presentations spanning ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. By uniting leading voices across disciplines and sectors, the symposium aims to accelerate translational progress in fertility and developmental science. The cross-sector collaboration is a key highlight, connecting experts from academia, biotechnology, and fertility clinics in a setting designed to promote discussion, networking, and new scientific partnerships.
Featured speakers include Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh; Ali H. Brivanlou of The Rockefeller University; Rafael Fissore of the University of Massachusetts Amherst; Ehsan Habibi of the Ottawa Hospital Research Institute and University of Ottawa; Jonathan van Blerkom of the University of Colorado, Boulder; Dietrich M. Egli of Columbia University Irving Medical Center; and Elizebeth Carr, America's first IVF baby, speaker and advocate. Collectively, their work represents pioneering advances in ovarian biology, fertilization, egg activation, developmental competence, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The symposium's translational relevance extends to fertility treatment, assisted reproduction, stem cell science, and developmental medicine. The focused one-day format is built to maximize scientific exchange, audience engagement, and collaboration, offering a rare opportunity for researchers, clinicians, trainees, and innovators to engage directly with leaders whose work has helped define modern reproductive biology. The implications of the discussions could influence how fertility clinics approach egg activation and how researchers develop stem cell-based models of early human development.


